1 / 31

EAHP Survey 2015

EAHP Survey 2015. Report of quantitative and qualitative results Jonathan Underhill MRPharmS Medicines Optimisation Lead, Keele University Associate Director, Medicines and Prescribing Centre, NICE. Keele Centre for Medicines Optimisation School of Pharmacy, Keele University. Method.

amezquita
Download Presentation

EAHP Survey 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EAHP Survey 2015 Report of quantitative and qualitative results Jonathan Underhill MRPharmS Medicines Optimisation Lead, Keele University Associate Director, Medicines and Prescribing Centre, NICE

  2. Keele Centre for Medicines Optimisation School of Pharmacy, Keele University

  3. Method Survey drafted after survey sub-group meeting Revised after comments from sub-group Revised after comments from EAHP co-ordinators Survey Monkey used English and 15 other languages to cover 34 member countries 4 week answer period Weekly reminder emails Codes given to country co-ordinators to assist identification of responses

  4. Response rates

  5. UK Response rate ~ 18% Response rate ~40% with equal weighting for each country

  6. Survey design • Section 1 • General information about setting and workforce • Helps assess capacity/capability barriers • Section 2 • Specific questions about implementation of statements • Baseline position for each country • Implementation barriers • Section 3 • General issues around implementation readyness

  7. Section 2 questions

  8. Identifying the barriers to implementation Defined as a ‘negative response’

  9. Initial analysis of quantitative responses • For whole of Europe • By country • Identified 5 questions that appear to have biggest barriers to implementation • By mode and by mean • Mode: the number of countries that placed the question in the lowest 5 rated questions. • Mean: the mean percentage of negative responses to a question across all respondent countries

  10. The 5 questions with the most negative responses *Mode: The number of countries that placed the question in the lowest 5 rated questions. **Mean: The mean percentage of negative responses to a question across all respondent countries.

  11. 4.4 The pharmacists in our hospital enter all medicines used onto the patient’s medical record on admission. UK The numbers at the base of each bar show many responses this question received, by country.

  12. 4.5 The pharmacists in our hospital contribute to the transfer of information about medicines when patients move between and within healthcare settings. UK The numbers at the base of each bar show many responses this question received, by country.

  13. 6.4 The pharmacists in our hospital routinely publish hospital pharmacy practice research. UK The numbers at the base of each bar show many responses this question received, by country.

  14. 5.3 Our hospital uses an external quality assessment accreditation programme to assure our medicines use processes UK The numbers at the base of each bar show many responses this question received, by country.

  15. 1.1 The pharmacists in our hospital work routinely as part of multidisciplinary team. UK The numbers at the base of each bar show many responses this question received, by country.

  16. Section 3 questions‘Implementation readyness’

  17. For these graphs, a lower bar indicates a potential implementation barrier…….

  18. Implementation 1: The pharmacists within our hospital are aware of the 44 European Statements for Hospital Pharmacy. UK The numbers at the base of each bar show many responses this question received, by country.

  19. Implementation 2: The pharmacists within our hospital agree in principle with the Statements. UK The numbers at the base of each bar show many responses this question received, by country.

  20. Implementation 3: Our hospital has the capability* to implement all of the Statements now. UK *Capability: Does the organisation have staff with the right skills and experience to support the change effort?.

  21. Implementation 4: Our hospital has the capacity* to implement the Statements now. UK *Capacity: Does the organisation have the sufficient number of people or time to undertake the change?

  22. Implementation 5: My hospital is committed to help the pharmacy department implement the Statements. UK The numbers at the base of each bar show many responses this question received, by country.

  23. Implementation 6: Our hospital has the confidence to make changes and implement the Statements. UK

  24. Qualitative analysis

  25. Entering medicines on care record… "it is the doctors job to prescribe" “this is done by junior doctors”

  26. Transfer of information about medicines between healthcare settings… "Appropriate IT and staff resource"

  27. Publishing practice research… "Time and pressure of work plus a view that our work is not publishable when it often is" "Not a teaching hospital" "Lack of dedicated time for pharmacy practice research"

  28. Using external assurance for medicines use processes… "lack of recognised UK accreditation programme" "availability of suitable external programmes" "part of a regional benchmarking group and due to be peer reviewed Dec 15"

  29. Next steps…… • Final report end of June 2015 • Whole of Europe • Report for each of the 34 countries • Publication of 3 papers in EJHP: • Methodology employed • Key findings • Implications for implementation of the statements • Next survey October 2015

More Related